HBV News and Research

RSS
Dynamic HBsAg measurements predict HBV inactivity

Dynamic HBsAg measurements predict HBV inactivity

HLA-C/KIR genotype linked to HBeAg-positive HBV interferon response

HLA-C/KIR genotype linked to HBeAg-positive HBV interferon response

Renal risk factors for NA-treated HBV patients identified

Renal risk factors for NA-treated HBV patients identified

Real-world data confirm TDF efficacy for HBV

Real-world data confirm TDF efficacy for HBV

Resistance to prior antiviral agents impacts TDF response

Resistance to prior antiviral agents impacts TDF response

Monitoring HBcrAg levels could help optimise PEG-IFN therapy

Monitoring HBcrAg levels could help optimise PEG-IFN therapy

Rescue TDF monotherapy effective in multidrug resistant chronic HBV

Rescue TDF monotherapy effective in multidrug resistant chronic HBV

STAT4 variant predicts HBV IFNα response

STAT4 variant predicts HBV IFNα response

Study outlines new model to help predict age-related response to hepatitis B vaccine

Study outlines new model to help predict age-related response to hepatitis B vaccine

Roche announces availability of cobas HBVassay for use on cobas 4800 System

Roche announces availability of cobas HBVassay for use on cobas 4800 System

Roche's cobas HIV-1 viral load test approved by FDA for use on cobas 6800 and cobas 8800 Systems

Roche's cobas HIV-1 viral load test approved by FDA for use on cobas 6800 and cobas 8800 Systems

RBHS Chancellor leads study to eliminate chronic viral hepatitis

RBHS Chancellor leads study to eliminate chronic viral hepatitis

AGA issues six new clinical practice guidelines

AGA issues six new clinical practice guidelines

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

HBsAg may persist in chronic HBV patients beyond seroclearance

HBsAg may persist in chronic HBV patients beyond seroclearance

Combining medications may increase HBsAg loss in HBV patients

Combining medications may increase HBsAg loss in HBV patients

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Hiroshima University researchers report promising new avenue for treating hepatitis B

Hiroshima University researchers report promising new avenue for treating hepatitis B

Men on effective HIV therapy less likely to get HBV infection, shows research

Men on effective HIV therapy less likely to get HBV infection, shows research

HBV DNA levels guide antiviral treatment in chemotherapy setting

HBV DNA levels guide antiviral treatment in chemotherapy setting